Hualan Bio Attending the 2017 CPhI Worldwide Exhibition

Hualan Bio Attending the 2017 CPhI Worldwide Exhibition

From October 24-26, 2017, 2017 CPhI Worldwide Exhibition was held in Frankfurt. As the leading enterprises in domestic biological pharmaceutical industry, with the support of HulanBiological Engineering Inc., Hualan Biological Bacterin Co., Ltd. attended the exhibition.
Hualan Biological in 2017 CPhI Frankfurt Exhibition

In the exhibition, the customers from Columbia, Pakistan, Turkey and other countries showed great interest in our plasma and vaccine products, such as Human Albumin, IVIG, Inactivated Influenza Vaccine (Split virion), Inactivated, Meningococcal Polysaccharide Vaccine Group ACYW135, and etc. which could extend Hualan Bio's oversea business, and most of them were interested to visit Hualan Bio's facilities. For next step, Hualan Bio will strengthen the oversea business cooperation and build a new cooperation platform to all cooperation customers.
The Booth of Hualan Biolgocal in 2017 CPHI Frankfurt Exhibition 

评论

发表评论

此博客中的热门博文

Hualan Genetic Recombinant Anti-CTLA-4 Human Monoclonal Antibody Injection (Ipilimumab) Starting Clinical Trial

图片
Hualan Genetic Recombinant Anti-CTLA-4 Human Monoclonal Antibody Injection (Ipilimumab) Starting Clinical Trial On October 10, 2018, Hualan GeneticEngineering Co., Ltd . received the clinical approval document of "Recombinant Anti-CTLA-4 Human Monoclonal Antibody Injection" issued by the State Drug Administration, with the approval number of 2018L03080. According to the drug registration procedure, Hualan Genetic Engineering Co., Ltd will organize and implement clinical trials as soon as possible in accordance with the requirements of the national drug clinical trials after obtaining the approval documents for the above drug clinical trials, and will apply the product production approval documents and GMP certificate after completing the clinical trials. With the registered capital of RMB 100 million Yuan, Hualan Genetic Engineering Co., Ltd. was established in June 2013. In May 2014, the company obtained Pharmaceutical Production License and devoted to the R...
阅读全文

What You Should Know About Flu Antiviral Drugs?

图片
What You Should Know About Flu Antiviral Drugs? 1. Can the flu be treated? Yes. There are prescription medications called “antiviral drugs” that can be used to treat flu illness. 2. What should I do if I think I have the flu? If you get the flu, antiviral drugs are a treatment option. Check with your doctor promptly if you are at high risk of serious flu complications (see box below for the full list of high risk factors) and you develop flu symptoms. Flu signsand symptoms can include feeling feverish or having a fever, cough, sore throat, runny or stuffy nose, body aches, headache, chills and fatigue. Your doctor may prescribe antiviral drugs to treat your flu illness. 3. Should I still get a flu vaccine? Yes. Antiviral drugs are not a substitute for getting a flu vaccine . While flu vaccine can vary in how well it works, a flu vaccine is best way to help prevent seasonal flu and its potentially serious complications. Antiviral drugs are a second li...
阅读全文

Summary of Hualan Bio’s IVIG, Human Immunoglobulin (pH4) for Intravenous Injection

图片
Summary of Hualan Bio’s IVIG, Human Immunoglobulin (pH4) for Intravenous Injection HumanImmunoglobulin (pH4) for Intravenous Injection, IVIG is a liquid preparation made from healthy human plasma, separated and purified by low temperature ethyl alcohol protein separation, and inactivated by double virus inactivation including at least 10 hours of Pap inactivated in 60 ± 0.5 ℃ and at least 21 days of low ph incubation at 23 ~ 25 ℃ . The active ingredient is humanimmunoglobulin , and contains appropriate amount of maltose, polysorbate 80 as a stabilizer, without preservatives and antibiotics. Clinically, it is mainly used to treat various primary and secondary immunoglobulin deficiency diseases and some autoimmune diseases.  HualanBio’s IVIG, Human Immunoglobulin (pH4) forIntravenous Injection
阅读全文